TERM OF GRANT. The license granted under Section 2.1 shall remain in full force and effect until the date which is the twenty-fifth (25th) anniversary of the Original Effective Date, unless this Agreement is terminated earlier pursuant to Article 11.
Appears in 3 contracts
Sources: License and Development Agreement (NUCRYST Pharmaceuticals Corp.), License and Development Agreement (NUCRYST Pharmaceuticals Corp.), License and Development Agreement (NUCRYST Pharmaceuticals Corp.)